Search

9 May 2022: Tetrabutylammonium (4'methyl-[2,2'bipyridin]-5yl)methanesulfonate is a ligand for iridium to control regioselectivity of iridium-catalysed borylation

9 May 2022: Hybridoma cell line producing SIg 375 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: Hybridoma cell line producing SIg 482 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

9 May 2022: Hybridoma cell line producing SIg 743 antibodies raised against sheep immunoglobulin G which are mouse monoclonal antibodies of the IgG isotype.

11 Apr 2022: Nyobolt is a University spin out from the Yusuf Hamied Department of Chemistry, commercialising a novel ultra-high power battery technology

3 May 2022: The Chris Abell Postdoc Business Plan Competition is a programme designed to help accelerate the creation of businesses from University research.

9 May 2022: KARPAS 620 Human Plasma Cell Leukemia cell line useful in oncology research, developed at the University of Cambridge.

9 May 2022: Hybridoma cell line producing YTH 862.2 antibodies raised against human HLA-class I which are rat monoclonal antibodies of the IgG2b isotype.

11 Apr 2022: This initiative links the Universities of Cambridge, Lincoln, Reading, Hertfordshire, and East Anglia to drive commercialisation of agri-tech research and innovation.

9 May 2022: Hybridoma cell line producing IR CT-1 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

17 Jan 2022: synthetic methods and critical reaction data. — patents, journals and news stories that feature the compound. — ... patents, journals and news stories that feature the compound (patent information is generally made Open by the patent offices – PMR).

9 May 2022: Hybridoma cell line producing IR 83-7 antibodies raised against the human insulin receptor, which are mouse monoclonal antibodies of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR CT-3 antibodies against the C-terminal portion of the human insulin receptor beta subunit, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 47-9 antibodies raised against the alpha subunit of the human insulin receptor,which are monoclonals of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-45 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG1 isotype.

9 May 2022: Hybridoma cell line producing IR 18-43 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 18-42 antibodies against the beta subunit N-terminal region of the human insulin receptor, which are of the IgG2b isotype.

28 Apr 2022: Cambridge Enterprise leads £1 million investment in 52 North Health, a UK and US-based med-tech start-up.

9 May 2022: Hybridoma cell line producing IR 83-14 antibodies against the alpha subunit of the human insulin receptor, which are mouse monoclonals of the IgG2a isotype.

9 May 2022: Hybridoma cell line producing IR 83-12 antibodies raised against the extracellular domain of the human insulin receptor, which are of the IgG1 isotype.